Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,31 CAD | +24,00% | +24,00% | +34,78% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 65 | 01-10-86 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 29-03-10 |
Guy-Paul Allard
LAW | General Counsel | 56 | 01-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Tinmouth
BRD | Director/Board Member | - | 28-04-04 |
Steven Saviuk
CEO | Chief Executive Officer | 65 | 01-10-86 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 29-03-10 |
Marc Bélair
BRD | Director/Board Member | - | 03-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 661 276 | 4 880 389 ( 38,55 %) | 0 | 38,55 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
VALEO PHARMA INC. 25.72% | 25 372 987 | 25.72% | 1 649 244 $ |
CHITOGENX INC. 10.34% | 5 275 392 | 10.34% | 242 668 $ |
Bedrijfsgegevens
Manitex Capital, Inc.
16667 Hymus Boulevard
H9H 4R9, Kirkland
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,78% | 2,85 mln. | |
+45,82% | 765 mld. | |
+40,95% | 632 mld. | |
-6,16% | 354 mld. | |
+19,86% | 331 mld. | |
+9,32% | 299 mld. | |
+18,45% | 248 mld. | |
-0,78% | 219 mld. | |
+11,88% | 216 mld. | |
+5,90% | 164 mld. |